3-Scenario Framework
📊 Base Case (50% Probability)
Key Variables: Steady macro (NA/EU tech spend +3–5%) + AI tool adoption scales linearly (50–75 bps annual margin tailwind).
- Revenue grows 15–17% YoY, driven by BFSI/Healthcare modernization and hi-tech product development. Top 100 clients expand at 18–20% YoY.
- EBIT margin stabilizes at 14–15%, with labour code impact offset by AI productivity gains. Operating cash flow recovers to 95–100% of PAT as DSO normalizes to 55 days.
- EPS rises to ₹30–32, supporting dividend hikes (₹24–26/share) and selective M&A for AI/data capabilities.